2009Science Technology and EngineeringRequires access

Effects of Atorvastatin on Pressure Overload-induced Cardiac Hypertrophy Mediated by Calcineurin

Duan Yun-yan

Open publisher page 0 citations

Abstract

To investigate the effects of atorvastatin on cardiac hypertrophy mediated by calcineurin in rats with pressure-overload,Sprague-Dawley rats were randomly allocated into three groups:The sham-operated groups(n=10),model groups(n=10) and atorvastatin-treated groups(n=10).The model of pressure overload was established by abdominal arota constriction.At the end of the treatment period,the left ventricular weight/body weight ratio,left ventricular mass,wall thickness(by echocardiography),myocardial content of CaN and CaNmRNA(by westernblot and RT-PCR) were assessed.It is resulted that ① The left ventricular weight/body weight ratio of model group,as well as atorvastatin-treated group,was significantly higher than sham-operated group(P0.05);compared with model group,the ratio was lower in atorvastatin-treated group(P0.05).② observed a higher level of CaN and CaNmRNA expression in model group,as well as atorvastatin-treated group,as compared to sham-operated group(P0.05);significant higher level of CaN and CaNmRNA expression was observed in model group compared to atorvastatin-treated group(P0.05).The present data suggests that atorvastatin may inhibit calcineurin-mediated hypertrophy in rats with pressure-overload.

About this research paper

What this paper is about

To investigate the effects of atorvastatin on cardiac hypertrophy mediated by calcineurin in rats with pressure-overload,Sprague-Dawley rats were randomly allocated into three groups:The sham-operated groups(n=10),model groups(n=10) and atorvastatin-treated groups(n=10).The model of pressure overload was established by abdominal arota constriction.At the end of the treatment period,the left ventricular weight/body weight ratio,left ventricular mass,wall thickness(by echocardiography),myocardial content of CaN and CaNmRNA(by westernblot and RT-PCR) were assessed.It is resulted that ① The left ventricular weight/body weight ratio of model group,as well as atorvastatin-treated group,was significantly higher than sham-operated group(P0.05);compared with model group,the ratio was lower in atorvastatin-treated group(P0.05).② observed a higher level of CaN and CaNmRNA expression in model group,as well as atorvastatin-treated group,as compared to sham-operated group(P0.05);significant higher level of CaN and CaNmRNA expression was observed in model group compared to atorvastatin-treated group(P0.05).The present data suggests that atorvastatin may inhibit calcineurin-mediated hypertrophy in rats with pressure-overload.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To investigate the effects of atorvastatin on cardiac hypertrophy mediated by calcineurin in rats with pressure-overload,Sprague-Dawley rats were randomly allocated into three groups:The sham-operated groups(n=10),model groups(n=10) and atorvastatin-treated groups(n=10).The model of pressure overload was established by abdominal arota constriction.At the end of the treatment period,the left ventricular weight/body weight ratio,left ventricular mass,wall thickness(by echocardiography),myocardial content of CaN and CaNmRNA(by westernblot and RT-PCR) were assessed.It is resulted that ① The left ventricular weight/body weight ratio of model group,as well as atorvastatin-treated group,was significantly higher than sham-operated group(P0.05);compared with model group,the ratio was lower in atorvastatin-treated group(P0.05).② observed a higher level of CaN and CaNmRNA expression in model group,as well as atorvastatin-treated group,as compared to sham-operated group(P0.05);significant higher level of CaN and CaNmRNA expression was observed in model group compared to atorvastatin-treated group(P0.05).The present data suggests that atorvastatin may inhibit calcineurin-mediated hypertrophy in rats with pressure-overload.

Key concepts: Atorvastatin, Pressure overload, Calcineurin, Medicine, Rat model, Myocardial hypertrophy, Internal medicine, Muscle hypertrophy

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Atorvastatin on Pressure Overload-induced Cardiac Hypertrophy Mediated by Calcineurin — Research Paper | ScholarLens